Right ventricular cardiomyocyte apoptosis in patients with acute myocardial infarction of the left ventricular wall.
Cardiac remodeling after acute myocardial infarction (AMI) is characterized by molecular and cellular mechanisms involving both the left (LV) and right ventricular (RV) walls. Cardiomyoycte apoptosis in the peri-infarct and remote LV myocardium has a central role in cardiac remodeling. Whether apoptosis also occurs in the right ventricle of patients with ischemic heart disease has not been investigated. The aim of the present study was to investigate the presence of cardiomyocyte apoptosis in the right ventricle in patients with AMI. We assessed the number of apoptotic cardiomyocytes using multiple samplings in the LV and RV walls of 12 patients selected at autopsy who died 4 to 42 days after AMI. Five patients without cardiac disease were also selected at autopsy as controls. Apoptotic rates were calculated from the number of cardiomyocytes showing double positive staining for in situ end-labeling of DNA fragmentation (TUNEL) and for activated caspase-3. Potentially false-positive results (DNA synthesis and RNA splicing) were excluded from cell counts. The apoptotic rate in the right ventricle in patients with AMI was significantly higher than in control hearts (median 0.8%, interquartile range 0.3 to 1.0 vs median 0.01%, interquartile range 0.01 to 0.03, p <0.001). RV apoptosis significantly correlated with such parameters of global adverse remodeling as cardiac diameter to LV free wall thickness (R = +0.57, p = 0.050). RV apoptosis was significantly higher in five cases (42%) with infarct involving the ventricular septum and an adjacent small area of the RV walls (median 1.0%, interquartile range 0.8 to 2.2 vs median 0.5%, interquartile range 0.2 to 1.0, p = 0.048, p <0.001 vs controls). The association between apoptotic rate in the right ventricle and cardiac remodeling was apparent even after exclusion of cases with RV AMI involvement (R = +0.82, p = 0.023 for diameter to LV wall thickness ratio and R = -0.91, p = 0.002 for RV free wall thickness). In conclusion, patients with cardiac remodeling after AMI had a significant increase in RV apoptosis even when ischemic involvement of the RV wall was not apparent.
Abbate
Antonio
A
Virginia Commonwealth University, Pauley Heart Center, Richmond, Virginia, USA. abbatea@yahoo.com
Bussani
Rossana
R
Sinagra
Gianfranco
G
Barresi
Elena
E
Pivetta
Alberto
A
Perkan
Andrea
A
Hoke
Nicholas H
NH
Salloum
Fadi N
FN
Kontos
Michael C
MC
Biondi-Zoccai
Giuseppe G L
GG
Vetrovec
George W
GW
Sabbadini
Gastone
G
Baldi
Feliciano
F
Silvestri
Furio
F
Kukreja
Rakesh C
RC
Baldi
Alfonso
A
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D017209:Apoptosis; D016022:Case-Control Studies; D005260:Female; D006346:Heart Septum / Q000473:pathology; D006352:Heart Ventricles / Q000473:pathology*; D006801:Humans; D020287:In Situ Nick-End Labeling; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000473:pathology*; D032383:Myocytes, Cardiac / Q000473:pathology*; D020257:Ventricular Remodeling
J Cell Physiol. 2002 Nov;193(2):145-53
12384991
Prog Cardiovasc Dis. 1982 Nov-Dec;25(3):225-67
6755555
Am J Physiol Heart Circ Physiol. 2001 Feb;280(2):H674-83
11158966
J Clin Pathol. 2002 Nov;55(11):801-11
12401816
Int J Cardiol. 2004 Mar;94(1):105-10
14996483
Circulation. 2006 Oct 24;114(17):1883-91
17060398
J Mol Cell Cardiol. 2002 Feb;34(2):165-74
11851356
Am J Cardiol. 1991 Nov 18;68(14):7D-16D
1836099
J Am Coll Cardiol. 2001 Dec;38(7):2101-13
11738322
Am J Cardiol. 1993 Nov 15;72(15):1126-30
8237800
Am J Cardiol. 2007 Feb 1;99(3):307-9
17261387
Am J Cardiol. 1988 Jul 11;62(2):14A-19A
3389301
Am J Physiol. 1991 Apr;260(4 Pt 2):H1379-84
1826414
Cardiovasc Drugs Ther. 1988 May;2(1):41-6
3154693
J Am Coll Cardiol. 1995 Apr;25(5):1143-53
7897128
Am J Physiol. 1998 May;274(5):H1812-20
9612394
Circulation. 1990 Apr;81(4):1161-72
2138525
J Clin Pathol. 2003 Sep;56(9):672-6
12944550
J Am Coll Cardiol. 2003 Mar 5;41(5):753-60
12628718
J Am Coll Cardiol. 1999 Oct;34(4):974-82
10520778